Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gaebel

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Acta Psychiatrica Scandinavica|September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?R Schennach, M Riesbeck, A Mayr, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 15, 2011
Preventing progression to first-episode psychosis in early initial prodromal statesA Bechdolf, M Wagner, S Ruhrmann, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 12, 2011
The validity of self-rated psychotic symptoms in depressed inpatientsF Seemüller, M Riedel, M Obermeier, et al.
Pharmacopsychiatry|September 3, 2008
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measuresM Jäger, T Messer, G Laux, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderR Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 9, 2016
European Psychiatric Association Guidance on psychotherapy in chronic depression across EuropeA Jobst, E-L Brakemeier, A Buchheim, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 1998
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, ItalyJ M Kane, E Aguglia, A C Altamura, et al.
Acta Psychiatrica Scandinavica|October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleR Schennach-Wolff, M Obermeier, F Seemüller, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Acta Psychiatrica Scandinavica|September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?R Schennach, M Riesbeck, A Mayr, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 15, 2011
Preventing progression to first-episode psychosis in early initial prodromal statesA Bechdolf, M Wagner, S Ruhrmann, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 12, 2011
The validity of self-rated psychotic symptoms in depressed inpatientsF Seemüller, M Riedel, M Obermeier, et al.
Pharmacopsychiatry|September 3, 2008
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measuresM Jäger, T Messer, G Laux, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderR Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 9, 2016
European Psychiatric Association Guidance on psychotherapy in chronic depression across EuropeA Jobst, E-L Brakemeier, A Buchheim, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 1998
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, ItalyJ M Kane, E Aguglia, A C Altamura, et al.
Acta Psychiatrica Scandinavica|October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleR Schennach-Wolff, M Obermeier, F Seemüller, et al.
Pageof 20